Muscle sections were blocked with 2% FBS in 1 × PBS for 30 min. The sections were incubated with primary antibodies against human-specific spectrin (1:50 mouse monoclonal IgG2b NCL-spec1, Novocastra; Leica Biosystems, Wetzlar, Germany) human-specific lamin A/C (1:300 mouse monoclonal IgG1 Ab40567; Abcam, Cambridge, UK), or laminin (1:400 diluted, Z0097, Dako) for 1 h and further incubated with appropriate secondary antibodies for 1 h. When necessary, β-gal detection was performed using a chicken antibody (Invitrogen AB9361; 1:1,000; 1 h). Pax7 staining was performed using a mouse monoclonal antibody (1:20; Developmental Studies Hybridoma Bank, Iowa City, IA) after a 10-min fixation with 4% paraformaldehyde. Fiber type composition was obtained using an anti-MYHC-I antibody (A4.840, 1:50; Developmental Studies Hybridoma Bank) and an anti-MYHC-II antibody (A4.74, 1:50; Developmental Studies Hybridoma Bank). Macrophages and neutrophils were stained with the F4/80 antibody (MCA497BB, 1:50; Bio-Rad) and Ly6g antibody (Ab25377, 1:100; Abcam), respectively, after a 10-min fixation with 4% paraformaldehyde. Finally, the sections were incubated for 10 min with Hoechst (0.5 μg/mL, Hoechst No. 33258; Sigma-Aldrich) and mounted with a mounting medium (Cytomation fluorescent mounting medium, S3023, Dako; Agilent Technologies, France).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.